| Assessment of FOXP3 Gene Polymorphisms and Serum Interleukin 10 in Patients With ITP (NCT05410249) | Sohag University | 2022-06-10 |
| Hetrombopag for the Thrombocytopenia Induced by Concurrent Chemoradiotherapy (NCT06433830) | Sir Run Run Shaw Hospital | 2022-05-10 |
| Study of Avatrombopag for Temozolomide-induced Thrombocytopenia in Glioma (APATIT-G) (NCT04931849) | University of Rochester | 2022-05-06 |
| Efficacy and Safety of Avatrombopag for Treating TCP in HBV-ACLF Patients Receiving ALSS Treatment (NCT05382013) | Third Affiliated Hospital, Sun Yat-Sen University | 2022-04-27 |
| National Vaccine Adverse Event Reporting Survey and Etiology (NCT05095844) | Neuroganics LLC | 2022-03-15 |
| Effects of Recombinant Human Thrombopoietin on Platelet Levels in ICU Patients (NCT05217719) | Nanfang Hospital, Southern Medical University | 2022-02-01 |
| Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia (NCT05199909) | Institute of Hematology & Blood Diseases Hospital, China | 2022-01-25 |
| A Phase Ib Clinical Study for rhTPO in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease (NCT05193201) | Shenyang Sunshine Pharmaceutical Co., LTD. | 2022-01-16 |
| Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study (NCT05396157) | Mount Sinai Hospital, Canada | 2021-11-01 |
| Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study (NCT05053100) | Mayo Clinic | 2021-08-17 |
| Treatment of Avatrombopag for Thrombocytopenia in Patients Undergoing Selective Resection of Hepatocellular Carcinoma (NCT05087459) | Shanghai Zhongshan Hospital | 2021-06-30 |
| Efficacy and Safety of Avatrombopag in Cancer Patients With Thrombocytopenia (NCT04896528) | Peking Union Medical College Hospital | 2021-06-06 |
| A Clinical Trial of Chidamide in the Management of Refractory ITP (NCT03838354) | Shandong University | 2021-06-01 |
| The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia (NCT05353673) | Peking University People's Hospital | 2021-06-01 |
| Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis (NCT04800458) | University Hospital, Bordeaux | 2021-05-19 |
| Fostamatinib as a Single Agent or in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis With Severe Thrombocytopenia (NCT04543279) | Washington University School of Medicine | 2021-05-03 |
| Collection of the Thrombo-VaxCov Cohort (NCT04889326) | University Hospital, Lille | 2021-04-02 |
| Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma (NCT04797182) | Sun Yat-sen University | 2021-04-01 |
| Thrombosomes® in Bleeding Thrombocytopenic Patients Study (NCT04631211) | Cellphire Therapeutics, Inc. | 2021-03-05 |
| Avatrombopag in Patients With End-stage Liver Disease and Thrombocytopenia (NCT04906083) | Tongji Hospital | 2021-02-01 |
| Platelet Augmentation Using C. Papaya Leaf Extract in Live Donor Liver Transplantation (NCT05360134) | Institute of Liver and Biliary Sciences, India | 2021-01-01 |
| Effect of Herbal Formulation on Thrombocytes Count (NCT05563064) | Shifa Ul Mulk Memorial Hospital | 2021-01-01 |
| Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma (NCT04673266) | Memorial Sloan Kettering Cancer Center | 2020-12-14 |
| Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker (NCT04003220) | University Hospital, Bordeaux | 2020-09-07 |
| TPO-Mimetic Use in Children for Hematopoietic Failure (NCT04478227) | Anjali Sharathkumar | 2020-08-18 |
| Platelet Transfusion in Sepsis Trial (NCT03968484) | University Hospital Tuebingen | 2020-08-01 |
| Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) (NCT04272970) | Institut National de la Santé Et de la Recherche Médicale, France | 2020-07-07 |
| Avatrombopag for Thrombocytopenia in People With Cancer (NCT04437953) | Memorial Sloan Kettering Cancer Center | 2020-05-27 |
| Avatrombopag on the Treatment of Thrombocytopenia Induced by Chemotherapy of Malignant Tumors (NCT04609891) | Anhui Provincial Cancer Hospital | 2020-05-26 |
| Bioequivalence Test of Eltrombopag Olamine Tablets in Humans Under Fasting State (NCT06768632) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2020-01-02 |
| HIV Indicator Diseases in Hospital and Primary Care (NCT05225493) | Erasmus Medical Center | 2020-01-01 |
| Safety of Acupuncture and Intracutaneous Needles in Pediatric Cancer Patients: a Retrospective Study (ACUSAFE2021) (NCT05585463) | Fundació Sant Joan de Déu | 2019-09-01 |
| Perioperative Eltrombopag in Patients With Inherited Thrombocytopenia (NCT03638817) | University Hospital, Toulouse | 2019-08-02 |
| Post-Operative Thrombocytopenia After Bio-prosthesis Implantation (NCT03835598) | Maastricht University Medical Center | 2019-06-28 |
| The SOLID Platelet Study (NCT03712618) | National Institutes of Health Clinical Center (CC) | 2019-06-10 |
| A Prospective, Open, Multicenter Clinical Trial of Eltrombopag Combined With Diacerein in Eltrombopag-inefficient or Relapsed ITP (NCT03754634) | Shandong University | 2019-05-01 |
| A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia (NCT03806556) | Meghan McCormick | 2019-04-22 |
| The Effect of REcombinant Human Thrombopoietin (rhTPO) on Sepsis Patients With aCUte Severe thrombocytopEnia (NCT02707497) | Ruilan Wang | 2019-04-01 |
| XIENCE 28 USA Study (NCT03815175) | Abbott Medical Devices | 2019-02-25 |
| Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients (NCT03998059) | Institute of Hematology & Blood Diseases Hospital, China | 2019-01-23 |
| Immunogenicity and Thrombotic Potential of Circulating Protamine-heparin Complexes in Cardiac Surgery Patients (NCT06565364) | Medical University of Vienna | 2019-01-07 |
| Thrombocytopoiesis and Platelet Homeostasis in Infants With Bronchoplumonary Dysplasia (NCT04348799) | yangjie | 2019-01-01 |
| Function of Platelets Used for Transfusions (NCT05038722) | Sofia Ramström | 2018-11-22 |
| Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women (NCT03767803) | Progenity, Inc. | 2018-10-01 |
| High-dose Use of rhTPO in CIT Patients (NCT03633019) | First Affiliated Hospital Xi'an Jiaotong University | 2018-09-28 |
| Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML (NCT03701217) | Nanfang Hospital, Southern Medical University | 2018-09-10 |
| Mortality Due to Septic Shock Associated With Thrombocytopenia (NCT03617965) | Universidad de Guanajuato | 2018-08-15 |
| Avatrombopag for the Treatment of Thrombocytopenia in Adults With Chronic Liver Disease Undergoing a Procedure (NCT03554759) | Sobi, Inc. | 2018-07-02 |
| Eltrombopag vs. rhTPO to Increase Platelet Level After HSCT (NCT03515096) | Shenzhen Second People's Hospital | 2018-07-01 |
| Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis (NCT03303950) | University of Utah | 2018-03-30 |
| Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure (NCT03326843) | Sobi, Inc. | 2018-03-26 |
| Management and Outcomes of Anti-thrombotic Medication Use in Thrombocytopenia (NCT03288441) | Maastricht University Medical Center | 2018-03-20 |
| Thrombosomes® in Bleeding Thrombocytopenic Patients (NCT03394755) | Cellphire Therapeutics, Inc. | 2018-03-19 |
| Prolonged Isolated Thrombocytopenia After Allo-SCT : N-acetyl-L-cysteine (NAC) Versus Supportive Therapy (NCT03391856) | Peking University People's Hospital | 2018-03-01 |
| XIENCE 28 Global Study (NCT03355742) | Abbott Medical Devices | 2018-02-09 |
| Thrombocytopenia Drug Immune Validation of New Biological Test Diagnostic (NCT02862353) | Centre Hospitalier Universitaire de Saint Etienne | 2017-10-25 |
| Study of Sirolimus in CTD-TP in China (NCT03688191) | Peking Union Medical College Hospital | 2017-09-21 |
| Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia (NCT02948283) | City of Hope Medical Center | 2017-09-05 |
| Thrombocytopenia Induced by Chemotherapy (NCT03567798) | Socrates School Of Health | 2017-07-18 |
| Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia (NCT03195010) | Fred Hutchinson Cancer Center | 2017-06-09 |
| Platelet Reactivity in Septic Shock (NCT03716310) | Università degli Studi di Ferrara | 2017-04-01 |
| Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia (NCT03059030) | Northwestern University | 2017-03-16 |
| The INFUSE Trial - Intervening With Platelet Transfusions in Sepsis (NCT03090919) | Susan Smyth | 2017-01-03 |
| Efficacy of Sialic Acid GNE Related Thrombocytopenia (NCT02845609) | Hadassah Medical Organization | 2016-09-01 |
| Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis (NCT02805868) | Northwestern University | 2016-06-01 |
| Effect of Chorioamnionitis on Platelet Activation and Placental Vessel Among Preterm Infants by Wnt-Flt1 Signal Pathway (NCT03636698) | Guangdong Women and Children Hospital | 2016-06-01 |
| Study to Evaluate Safety, Tolerability and Efficacy of UCB7665 in Subjects With Primary Immune Thrombocytopenia (NCT02718716) | UCB Biopharma SRL | 2016-03-02 |
| A Multicenter Randomized Open-label Study of Oseltamivir Combined With HD-DEX Versus HD-DEX in the Management of ITP (NCT01965626) | Shandong University | 2016-02-01 |
| Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia (NCT02530515) | M.D. Anderson Cancer Center | 2015-12-18 |
| Prospective Study of Patients With Thrombocytopenia Following HSCT (NCT02487563) | The First Affiliated Hospital of Soochow University | 2015-10-01 |
| Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy (NCT02679443) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2015-07-01 |
| Cyclophosphamide and Hydroxychloroquine for Thrombocytopenia in SLE (NCT02444728) | Chinese SLE Treatment And Research Group | 2015-07-01 |
| Protocol for the Infusion of Buffy Coat-derived Cryopreserved Platelets in Patients With Severe Thrombocytopenia (NCT02032134) | Napolitano Mariasanta | 2015-07-01 |
| Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (NCT02389621) | Shionogi | 2015-06-15 |
| The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia Study (NCT02371330) | Karolinska Institutet | 2015-04-01 |
| Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia (NCT02298933) | National Heart, Lung, and Blood Institute (NHLBI) | 2014-11-21 |
| Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets (NCT02078284) | U.S. Army Medical Research and Development Command | 2014-11-05 |
| Observational Trial of a Therapeutic Platelet Transfusion Regimen (NCT02276651) | Klinikum Nürnberg | 2014-11-01 |
| Efficacy and Safety of rhTPO for the Treatment of Thrombocytopenia After Chemotherapy in AML Patients (NCT02267993) | Institute of Hematology & Blood Diseases Hospital, China | 2014-10-01 |
| Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia (NCT02244658) | Shandong University | 2014-09-01 |
| A Study of Eltrombopag in Patients With CMML and Thrombocytopenia (NCT02323178) | Groupe Francophone des Myelodysplasies | 2014-08-07 |
| Prevention of Thrombocytopenia in Glioblastoma Patients (NCT02227576) | University Hospital, Lille | 2014-07-10 |
| PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid) (NCT02074436) | Emory University | 2014-05-23 |
| rhTPO in Critical Patients With Thrombocytopenia (NCT02094248) | Jinling Hospital, China | 2014-03-01 |
| EMR Tool Impact on HIT Documentation and Management (NCT05439265) | Rush University Medical Center | 2014-01-01 |
| A Five-Treatment-Period Study to Evaluate the Single-Dose Pharmacokinetics and Pharmacodynamics of Avatrombopag in Healthy Japanese and White Subjects (NCT02039076) | Eisai Inc. | 2013-12-01 |
| French Adult Primary Immune Thrombocytopenia (NCT03429660) | University Hospital, Toulouse | 2013-10-01 |
| Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia. (NCT01791101) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2013-09-16 |
| Bleeding Prediction in Thrombocytopenia (NCT02306044) | Pernille Just Vinholt | 2013-04-01 |
| Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C (NCT01821625) | University of Texas Southwestern Medical Center | 2013-04-01 |
| Evaluate the Association Between Infection and Thrombocytopenia (NCT02263157) | Jinling Hospital, China | 2013-01-01 |
| Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy (NCT01676961) | NYU Langone Health | 2013-01-01 |
| Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia (NCT01727401) | G. d'Annunzio University | 2012-11-01 |
| Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant (NCT01660347) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2012-08-01 |
| Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma (NCT01484314) | Dana-Farber Cancer Institute | 2012-04-01 |
| Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients (NCT01444417) | Amgen | 2012-01-01 |
| Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501 (NCT01355289) | Eisai Inc. | 2011-11-01 |
| Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG) (NCT01397149) | University of Ulm | 2011-10-01 |
| Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS) (NCT01481220) | Nordic MDS Group | 2011-10-01 |
| Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic Syndromes (NCT02912208) | Associazione Qol-one | 2011-06-11 |